RegentAtlantic Capital’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.52M | Buy |
18,871
+1,735
| +10% | +$140K | 0.05% | 242 |
|
|
2022
Q2 | $1.28M | Buy |
17,136
+1,224
| +8% | +$91.2K | 0.04% | 268 |
|
|
2022
Q1 | $2.04M | Sell |
15,912
-1,860
| -10% | -$238K | 0.06% | 220 |
|
|
2021
Q4 | $2.39M | Buy |
17,772
+1,936
| +12% | +$260K | 0.07% | 200 |
|
|
2021
Q3 | $2.17M | Buy |
15,836
+3,160
| +25% | +$432K | 0.07% | 203 |
|
|
2021
Q2 | $1.35M | Buy |
12,676
+3,800
| +43% | +$406K | 0.04% | 253 |
|
|
2021
Q1 | $797K | Buy |
8,876
+1,072
| +14% | +$96.3K | 0.03% | 308 |
|
|
2020
Q4 | $721K | Sell |
7,804
-5,576
| -42% | -$515K | 0.03% | 283 |
|
|
2020
Q3 | $1.38M | Buy |
+13,380
| New | +$1.38M | 0.06% | 194 |
|